Stool transplant to treat early C. difficile infection
Treatments studied
Part of Infections clinical trials.
This trial tests whether giving a stool transplant (also called FMT) can treat a new, early C. difficile infection in people who have improved while on antibiotics. It may help some people prevent the infection from coming back or worsening.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are older than 18 years
- Your stool test for C. difficile PCR is positive and you have symptoms like diarrhea/enteritis
- Your diarrhea fully went away during the antibiotics used to treat this C. difficile infection
- You are not taking any other antibiotics now and not taking probiotics now
- You can sign consent (for example, you are not unable to consent due to dementia)
- You can hold the enema safely (no severe fecal incontinence)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows patients who were treated for a C. difficile infection (a serious gut bacteria infection) at Umeå University Hospital to compare how well they recover long-term with either a fecal microbiota transplant (FMT—transferring healthy gut bacteria from a donor) or antibiotic treatment alone.
This study tests if a freeze-dried fecal transplant (FMT) can help people with difficult-to-treat diarrhea caused by IBS-D or recurring C. diff infections. It's a way to restore healthy gut bacteria and may reduce symptoms.
This trial tests whether a stool transplant (fecal microbiota transplantation) can help manage active ulcerative colitis. You would receive a transplant from a healthy donor to see if it improves your symptoms.
This trial compares three treatments for Clostridioides difficile infection (a severe diarrhea caused by bacteria) to see which works best and prevents it from coming back. It tests a fecal microbiota transplant (FMT, transferring healthy donor stool), fidaxomicin, and vancomycin, all given by mouth or tube.
This study looks at “rescue” fecal microbiota transplantation (FMT), which replaces gut microbes using stool from a screened donor, for intestinal infections that have not improved with standard care. It may help patients whose infection keeps coming back or doesn’t respond to treatment.
This study looks at fecal microbiota transplantation (FMT), which is a stool bacteria transplant, to help adults whose symptoms persist or return, often from C. difficile infection. If you’re already planning or receiving FMT for certain conditions, this trial may add information on how it helps and who benefits.
Hear when a new Clostridioides Difficile Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.